Clinical Trials Logo

Clinical Trial Summary

This study aimed to analyze perioperative information in patients with high-grade squamous intraepithelial lesion (HSIL) undergoing total hysterectomy (TH), offering insights into optimal surgery timing, selecting the operation path, and enhancing surgical operation details.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06325592
Study type Observational
Source Sichuan Cancer Hospital and Research Institute
Contact
Status Completed
Phase
Start date October 1, 2023
Completion date March 1, 2024

See also
  Status Clinical Trial Phase
Completed NCT04177641 - Evaluation of Thioldisulfide Balance in Cervical Preinvasive Lesions
Recruiting NCT05210348 - Clinical Evaluation of Detection of High Risk HPV in Urine
Not yet recruiting NCT04115787 - Conservative Management in Patients Diagnosed With Grade 2 or Grade 3 CIN
Active, not recruiting NCT02576561 - Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL Phase 2
Active, not recruiting NCT05613283 - Primary Cervical Cancer Screening by Self-sampling HPV Test
Not yet recruiting NCT06333743 - Laser Ablation in the Treatment of High-grade Cervical Lesions N/A
Completed NCT03920800 - Preventing Invasive Cervical Cancer: The Importance of Expectant Management in Young Women With High-grade Pre-cancerous Lesions
Completed NCT03239223 - Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection Phase 1
Not yet recruiting NCT06233331 - Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV Phase 1